Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Retrospective Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

NCT02420366 is registered in ClinicalTrials.gov with Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) as lead sponsor.

NCT NCT02420366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02420366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Retrospective Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
Lead sponsor
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
January 31, 2015
Enrollment
257 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute pyelonephritis, bacteremia, hospital acquired bacterial pneumonia, urinary tract infection, complicated, ventilator-associated bacterial pneumonia